Back to search

Article

Proteomic profiling of baseline CSF and serum from HDClarity identifies signatures for Huntington disease staging and stratification

2026-08-12

Abstract excerpt

<h4>Background</h4> Sensitive biomarkers that objectively stage Huntington disease (HD) are needed to improve participant stratification and facilitate the enrichment of clinical trials with biologically and clinically homogeneous populations. The HDClarity study, an international longitudinal biofluid collection initiative for HD, provides a unique resource for large-scale proteomic profiling of matched CSF and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
aedbf66d-c88b-5072-ad4d-aa0be8d2ddd6
DOI
10.64898/2026.08.06.743256
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Proteomic profiling of baseline CSF and serum from HDClarity identifies signatures for Huntington disease staging and stratificationDOI 10.64898/2026.08.06.743256
A Decade of Discovery of Huntington's Disease Biomarkers: A Comprehensive Review of its Established and Emerging Bi-omarkersSemantic proximity
Advances in Huntington’s Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive ReviewSemantic proximity
The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and agingSemantic proximity
Huntington’s Disease Integrated Staging System (HD-ISS): A Novel Evidence-Based Classification System For StagingSemantic proximity
Safety and feasibility of research lumbar puncture in Huntington’s disease: the HDClarity cohort and bioresourceSemantic proximity
Untargeted proteomics and stage-specific Huntington’s disease reveal biological pathways, and potential protein biomarkersSemantic proximity
Deep Plasma Proteomics Reveals Shared and Disease-Specific Molecular Signatures in Alzheimer’s Disease and Frontotemporal DementiaSemantic proximity
Mapping the circulating proteome across neurodegeneration: A harmonized, consortium-scale framework for uncovering molecular pathophysiologySemantic proximity
A biological classification of Huntington's disease: the Integrated Staging System.Semantic proximity
Proteomic profiling of CSF reveals stage-specific changes in Amyotrophic lateral sclerosis patientsSemantic proximity
Cerebrospinal Fluid Biomarkers for Huntington’s DiseaseSemantic proximity
Plasma gangliosides correlate with disease stages and symptom severity in Huntington’s disease carriersSemantic proximity
Select a neighboring publication to make it the new centre.